Payment overview · 2025
General Payments
$35.00
1 reported records · 1 companies
Healthcare provider profile · identity verified
Jay Daniel Dinovitser, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · ELLENVILLE, NY · NPI 1649583808
Verified facts
What the public records show
CMS Open Payments records show Jay Daniel Dinovitser, D.O. received $35.00 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $35.00 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.00 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $35.00 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 1036 | 97 |
| Famotidine | Famotidine | 813 | 74 |
| Gabapentin | Gabapentin | 555 | 47 |
| Amlodipine Besylate | Amlodipine Besylate | 470 | 71 |
| Tamsulosin Hcl | Tamsulosin Hcl | 454 | 51 |
| Mirtazapine | Mirtazapine | 388 | 42 |
| Furosemide | Furosemide | 380 | 29 |
| Losartan Potassium | Losartan Potassium | 376 | 36 |
| Metoprolol Succinate | Metoprolol Succinate | 371 | 42 |
| Finasteride | Finasteride | 320 | 25 |
| Eliquis | Apixaban | 313 | 34 |
| Levothyroxine Sodium | Levothyroxine Sodium | 285 | 25 |
| Escitalopram Oxalate | Escitalopram Oxalate | 273 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 255 | 28 |
| Memantine Hcl | Memantine Hcl | 246 | 20 |
| Carvedilol | Carvedilol | 227 | 26 |
| Levetiracetam | Levetiracetam | 223 | 17 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 222 | 30 |
| Januvia | Sitagliptin Phosphate | 211 | 16 |
| Hydralazine Hcl | Hydralazine Hcl | 199 | 28 |
| Lisinopril | Lisinopril | 185 | 22 |
| Nifedipine Er | Nifedipine | 172 | 17 |
| Donepezil Hcl | Donepezil Hcl | 144 | 12 |
| Torsemide | Torsemide | 144 | 18 |
| Sevelamer Carbonate | Sevelamer Carbonate | 143 | 16 |
| Pantoprazole Sodium | Pantoprazole Sodium | 141 | 25 |
| Metoprolol Tartrate | Metoprolol Tartrate | 134 | 17 |
| Metformin Hcl | Metformin Hcl | 131 | 20 |
| Glipizide Er | Glipizide | 130 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 123 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 122 | 12 |
| Montelukast Sodium | Montelukast Sodium | 121 | 14 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 113 | 30 |
| Omeprazole | Omeprazole | 111 | 19 |
| Metformin Hcl Er | Metformin Hcl | 109 | suppressed |
| Novolog Flexpen | Insulin Aspart | 108 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 98 | suppressed |
| Spironolactone | Spironolactone | 94 | suppressed |
| Latanoprost | Latanoprost | 87 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 85 | 17 |
| Pioglitazone Hcl | Pioglitazone Hcl | 81 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 72 | suppressed |
| Baclofen | Baclofen | 71 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 71 | suppressed |
| Tradjenta | Linagliptin | 70 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 69 | suppressed |
| Xarelto | Rivaroxaban | 67 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 66 | suppressed |
| Ezetimibe | Ezetimibe | 64 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 64 | 16 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 63 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 62 | 13 |
| Jardiance | Empagliflozin | 62 | 16 |
| Entresto | Sacubitril/Valsartan | 61 | suppressed |
| Potassium Chloride | Potassium Chloride | 61 | 12 |
| Fluoxetine Hcl | Fluoxetine Hcl | 59 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 58 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 57 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 57 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 53 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 52 | 15 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 48 | suppressed |
| Sertraline Hcl | Sertraline Hcl | 48 | suppressed |
| Allopurinol | Allopurinol | 47 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 47 | 17 |
| Lactulose | Lactulose | 47 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 46 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 46 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 45 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 44 | 16 |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 44 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 42 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 41 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 41 | suppressed |
| Levofloxacin | Levofloxacin | 41 | 35 |
| Sodium Chloride | 0.9 % Sodium Chloride | 40 | 18 |
| Midodrine Hcl | Midodrine Hcl | 39 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 39 | 15 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 39 | suppressed |
| Digoxin | Digoxin | 38 | suppressed |
| Folic Acid | Folic Acid | 38 | suppressed |
| Calcitriol | Calcitriol | 36 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 36 | 17 |
| Clonazepam | Clonazepam | 34 | suppressed |
| Anagrelide Hcl | Anagrelide Hcl | 33 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 33 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 33 | suppressed |
| Methotrexate | Methotrexate Sodium | 33 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 33 | suppressed |
| Brilinta | Ticagrelor | 32 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 32 | suppressed |
| Topiramate | Topiramate | 32 | suppressed |
| Methimazole | Methimazole | 31 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 30 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 30 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 30 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 30 | suppressed |
| Acetylcysteine | Acetylcysteine | 28 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 28 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 27 | suppressed |
| Haloperidol | Haloperidol | 27 | suppressed |
| Nystop | Nystatin | 27 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 27 | suppressed |
| Amantadine | Amantadine Hcl | 26 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 26 | suppressed |
| Myrbetriq | Mirabegron | 26 | suppressed |
| Ciclopirox | Ciclopirox Olamine | 25 | 13 |
| Hydroxyurea | Hydroxyurea | 25 | suppressed |
| Letrozole | Letrozole | 25 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 25 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 25 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 25 | suppressed |
| Atenolol | Atenolol | 24 | suppressed |
| Rhopressa | Netarsudil Mesylate | 24 | suppressed |
| Glipizide | Glipizide | 23 | suppressed |
| Pregabalin | Pregabalin | 23 | suppressed |
| Simvastatin | Simvastatin | 23 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 22 | suppressed |
| Cyclosporine | Cyclosporine | 22 | suppressed |
| Alogliptin | Alogliptin Benzoate | 21 | suppressed |
| Austedo Xr | Deutetrabenazine | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Ketoconazole | Ketoconazole | 21 | suppressed |
| Prednisone | Prednisone | 21 | suppressed |
| Xifaxan | Rifaximin | 20 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 19 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 19 | suppressed |
| Ozempic | Semaglutide | 19 | suppressed |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 19 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 19 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 18 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 17 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 17 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 16 | suppressed |
| Nitroglycerin | Nitroglycerin | 16 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 15 | suppressed |
| Trulicity | Dulaglutide | 15 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 15 | suppressed |
| Abacavir | Abacavir Sulfate | 14 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 14 | 14 |
| Clonidine | Clonidine | 14 | suppressed |
| Fanapt | Iloperidone | 14 | suppressed |
| Lamivudine Hbv | Lamivudine | 14 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 14 | suppressed |
| Mupirocin | Mupirocin | 14 | suppressed |
| Tivicay | Dolutegravir Sodium | 14 | suppressed |
| Wellbutrin Xl | Bupropion Hcl | 14 | suppressed |
| Admelog Solostar | Insulin Lispro | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 13 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 13 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 13 | suppressed |
| Zegerid | Omeprazole/Sodium Bicarbonate | 13 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Lumigan | Bimatoprost | 12 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 11 | suppressed |
| Humalog | Insulin Lispro | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Timolol Maleate | Timolol Maleate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.00 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error